Description:
* "PharmaZen
Limited is a global biotechnology company based in Dunedin, New Zealand.
Shares in the company are traded through Unlisted (www.unlisted.co.nz)
which is an unregistered securities trading facility. Trading in
securities quoted on Unlisted can only be undertaken via brokers. A list
of brokers can be found on the Unlisted website. PharmaZen
Ltd offers its international customer base a core capability in
formulating, manufacturing and marketing specialised animal and human
health products based on immune protective bioactive components and other
novel bioactive ingredients. PharmaZen
Ltd products are turnkey developed by PharmaZen's world-class scientific
and research teams which are in turn ably supported and assisted by
experienced in-house process and manufacturing experts."
Website: http://www.pharmazen.co.nz/
Recent announcements: click here
|
Year |
|
2002 |
2003 |
2004 |
2005 |
Average
GR |
Compounding
GR |
|
Gross
growth rates |
|
|
|
|
|||
|
Revenue |
|
|
82% |
-17% |
23% |
89% |
13% |
|
NPAT |
|
|
-113% |
-133% |
57% |
-188% |
-42% |
|
Total
Assets |
|
|
-7% |
-4% |
8% |
-3% |
-1% |
|
Net
Assets |
|
|
7% |
-2% |
-3% |
1% |
0% |
|
Per
Share figures and growth |
|||||||
|
Earnings |
|
$
(0.02) |
$
0.00 |
$
(0.00) |
$
(0.00) |
|
|
|
|
|
|
-113% |
-133% |
57% |
-188% |
-42% |
|
Net
Assets |
|
$
0.03 |
$
0.03 |
$
0.03 |
$
0.03 |
|
|
|
|
|
|
7% |
-2% |
-3% |
1% |
0% |
|
Dividends |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profitability |
|||||||
|
Return
on Assets |
|
-39% |
5% |
-2% |
-3% |
|
|
|
Equity
Multiplier |
|
1.38 |
1.21 |
1.19 |
1.33 |
|
|
|
Return
on Equity (ROE) |
|
-54% |
6% |
-2% |
-3% |
|
|
|
ROE
(avg E) |
|
-107% |
7% |
-2% |
-3% |
|
|
|
Net
Profit Margin |
|
-94% |
6% |
-3% |
-3% |
|
|
|
Dividend
payout ratio |
|
0% |
0% |
0% |
0% |
|
|
|
Liquidity |
|||||||
|
Net
working capital |
|
$
2,317,206 |
$
2,832,308 |
$
2,824,884 |
$
2,205,299 |
|
|
|
Current
ratio |
|
2.35 |
4.28 |
4.89 |
2.53 |
|
|
|
Acid
test ratio |
|
0.82 |
1.70 |
1.81 |
1.28 |
|
|
|
Other |
|||||||
|
Times
interest earned |
|
-5.33 |
7.05 |
-0.47 |
-3.27 |
|
|
|
Operating
exp/income |
|
111% |
90% |
101% |
103% |
|
|
|
|
|
|
|
|
|
|
|
|
Summary
Financials |
|||||||
|
Income |
|
517608 |
5440221 |
4534894 |
5595811 |
|
|
|
Expenses |
|
3364768 |
4967812 |
4608503 |
5797977 |
|
|
|
Tax |
|
-51382 |
120753 |
42655 |
-19442 |
|
|
|
NPAT |
|
-2795778 |
351656 |
-116264 |
-182724 |
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
7207066 |
6711806 |
6462290 |
6974414 |
|
|
|
Liabilities |
|
2001844 |
1154928 |
1021676 |
1716524 |
|
|
|
Net
Assets |
|
5205222 |
5556878 |
5440614 |
5257890 |
|
|
| Registered Office: Level 1 30 London Street Dunedin |
Mailing address: |
| Directors: Dr C T Hung Dr M G Shepherd Mr D Smallbone |
Secretary: |
| Auditors: Deloitte |
Solicitors: Downie Stewart |
| Bankers: National Bank Limited |
Registrar: |
| Accountant: Jackson Valentine Limited |
Other: |
| Other |
Company balance date: 31 October
Last updated: 07/01/2007
